UM

Browse/Search Results:  1-6 of 6 Help

Selected(0)Clear Items/Page:    Sort:
Scutellarin enhances anti-tumor immune responses by reducing TNFR2-expressing CD4+Foxp3+ regulatory T cells Journal article
Chen, Shaokui, Li, Ruixin, Chen, Yibo, Chou, Chon Kit, Zhang, Zhexuan, Yang, Yang, Liao, Ping, Wang, Qingqing, Chen, Xin*. Scutellarin enhances anti-tumor immune responses by reducing TNFR2-expressing CD4+Foxp3+ regulatory T cells[J]. Biomedicine and Pharmacotherapy, 2022, 151, 113187.
Authors:  Chen, Shaokui;  Li, Ruixin;  Chen, Yibo;  Chou, Chon Kit;  Zhang, Zhexuan; et al.
Favorite | TC[WOS]:9 TC[Scopus]:11  IF:6.9/6.8 | Submit date:2022/08/02
Cancer Immunotherapy  cd4+foxp3+ Regulatory t Cells  Cpg Oligodeoxynucleotide  Scutellarin  Tumor Necrosis Factor  Tumor Necrosis Factor Receptor Ii  
Use of scutellarin in a medicament and a modulator for preventing or treating diseases, medicament, and modulator Patent
专利类型: 发明专利Invention,
Authors:  Xin Chen;  Ruixin Li;  Shaokui Chen
Favorite |  | Submit date:2022/08/30
TNFR2-expressing CD4(+) Foxp3(+) regulatory T cells in cancer immunology and immunotherapy Book chapter
出自: Progress in Molecular Biology and Translational Science, CA:Elsevier, 2019, 页码:101-117
Authors:  Jiang He;  Ruixin Li;  Yibo Chen;  Yuanjia Hu;  Xin Chen
Favorite | TC[WOS]:16 TC[Scopus]:16 | Submit date:2019/05/08
Regulatory t Cells  Tumor Necrosis Factor  Tumor Necrosis Factor Receptor Type 2  Cancer  Immunotherapy  
TNFR2 and Regulatory T Cells: Potential Immune Checkpoint Target in Cancer Immunotherapy Book chapter
出自: Progress in Molecular Biology and Translational Science:ELSEVIER ACADEMIC PRESS INC, 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA, 2019, 页码:101-117
Authors:  Jiang He;  Ruixin Li;  Yibo Chen;  Yuanjia Hu;  Xin Chen
Favorite | TC[WOS]:16 TC[Scopus]:16 | Submit date:2020/05/05
Regulatory t Cells  Tumor Necrosis Factor Receptor Type 2  Cancer  Immunotherapy  Tumor Necrosis Factor  
TNFR2-expressing CD4+ Foxp3+ regulatory T cells in cancer immunology and immunotherapy Journal article
He, J., Li, Ruixin, Chen, Yibo, Hu, Yuanjia, Chen, Xin. TNFR2-expressing CD4+ Foxp3+ regulatory T cells in cancer immunology and immunotherapy[J]. Progress in Molecular Biology and Translational Science, 2019, 164, 101-117.
Authors:  He, J.;  Li, Ruixin;  Chen, Yibo;  Hu, Yuanjia;  Chen, Xin
Favorite | TC[WOS]:16 TC[Scopus]:16  IF:4.074/4.005 | Submit date:2022/05/23
Cancer  Immunotherapy  Regulatory t Cells  Tumor Necrosis Factor  Tumor Necrosis Factor Receptor Type 2  
Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents Journal article
Zou, Huimin, Li, Ruixin, Hu, Hao, Hu, Yuanjia, Chen, Xin. Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents[J]. FRONTIERS IN IMMUNOLOGY, 2018, 9.
Authors:  Zou, Huimin;  Li, Ruixin;  Hu, Hao;  Hu, Yuanjia;  Chen, Xin
Favorite | TC[WOS]:46 TC[Scopus]:49  IF:5.7/6.8 | Submit date:2018/10/30
Tnf Receptor Type Ii  Regulatory t Cells  Tnf Receptor Type Ii Agonists  Tnf Receptor Type Ii Antagonists  Immunotherapy